Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Open-Label, Multi-Center Study of a Group B Streptococcus Vaccine in HIV Positive and HIV Negative Pregnant Women

NCT01412801 is registered in ClinicalTrials.gov with Novartis Vaccines as lead sponsor.

NCT NCT01412801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01412801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Open-Label, Multi-Center Study of a Group B Streptococcus Vaccine in HIV Positive and HIV Negative Pregnant Women
Lead sponsor
Novartis Vaccines
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2011
Completion date
December 31, 2012
Enrollment
270 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infections, gram-positive bacterial infections, streptococcal infections